Funded Tech Companies
N30 Pharmaceuticals
Headquartered in Boulder, N30 Pharmaceuticals raised its funding from Jennison Associates, Deerfield Capital and Sabby Capital.
Company Overview
Company Name
N30 Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
3122 Sterling Cir. 200
Boulder, CO 80301
USA
Boulder, CO 80301
USA
Phone
Website
Email Address
Company Background Information
Overview
N30 Pharmaceuticals, LLC is developing s-nitrosothiol therapies for important unmet needs in respiratory diseases. N30's strategy focuses on administration of GSNO to the human airway, and development of small molecule inhibitors of GSNO reductase.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/20/2014
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jon Congleton
Chief Financial Officer
Tom Sokolowski
VP - R & D
Sherif Gabriel
VP - Regulatory Affairs
Janice Troha
Company Investors
- Jennison Associates
- Deerfield Capital (Howard Furst)
- Sabby Capital
- Wellington Management Company
- Rock Springs Capital
- RA Capital
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
Our data comes from VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs